We’re thrilled to share that NanoVation Therapeutics has been awarded the prestigious Deal of the Year award at the 27th Annual Life Sciences BC Awards! This recognition celebrates our partnership with Novo… Read More
Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS) Following this important milestone, Cosentyx has been listed… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)–Life Sciences BC (LSBC) is pleased to announce the recipients of the 27th Annual Life Sciences BC Awards. These awards honour the exceptional achievements of individuals and… Read More
Vancouver (BC), Toronto (ON), and Montreal (QC) (July 9, 2025) — Canada has developed a world-class life sciences sector, but without stronger domestic investment, much of the economic value and intellectual… Read More
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study to a Phase 2b placebo-controlled study. This is… Read More
